Recurrence: all 3,523 studies
Page 5 of 36. Open to participants first (870), then studies with results posted, then the rest; newest registration first within each.
- CD19 & CD22 Bispecific CAR T Cells in the Treatment of Relapsed/Refractory B Cell Hematologic TumorsRecruitingNCT06735495Phase 1/2
- A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed/ Refractory Multiple MyelomaRecruitingNCT06732232Early Phase 1
- A Clinical Study of CHT101 in CD70-Positive Advanced Solid TumorsRecruitingNCT06730659Phase 1
- A Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/ Refractory Plasma Cell LeukemiaRecruitingNCT06730256Early Phase 1
- Efficacy and Safety of Vorolanib Monotherapy As Third-line or Later Treatment for Advanced Non-small Cell Lung Cancer Patients: a Single-arm, Prospective, Open-label Phase II Clinical StudyRecruitingNCT06728852Phase 2
- Nissen Versus Dor Hiatal Hernia RepairRecruitingNCT06725433Not applicable
- Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis.RecruitingNCT06725173
- PEEL-224, Vincristine and Temozolomide in Pediatric Solid TumorsRecruitingNCT06721689Phase 1/2
- A Clinical Trial to Evaluate Effect of IAE0972 Combined with Chemotherapy for R/M HNSCC or NPC(Note: It is Currently Phase II.).Not yet recruitingNCT06719479Phase 2/3
- A Study of BL-M08D1 in Patients With Relapsed or Refractory Lymphoid MalignanciesRecruitingNCT06718634Phase 1
- a Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Plasma Cell LeukemiaRecruitingNCT06718270Early Phase 1
- A Crossover Clinical Study to Evaluate the Effect of Chitosan Mouthwash on Recurrence of Black Stains in Pediatric PatientsRecruitingNCT06714695Not applicable
- IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.RecruitingNCT06713837Phase 3
- Predicting Treatment Failure in HSIL Patients with Positive Margins After Conization Via Detection of PAX1 MethylationNot yet recruitingNCT06713655
- A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell MalignanciesRecruitingNCT06708897Phase 1
- A Follow-up Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis BEnrolling by invitationNCT06707922Not applicable
- Study on Recurrent Breast Cancer and Repeated Radiation TherapyRecruitingNCT06704659Not applicable
- WL276 CAR-T Cell Therapy for CD276 Positive Recurrent or Progressive Glioblastoma PatientsNot yet recruitingNCT06691308Early Phase 1
- Demethylating Agents Combined With Venetoclax for High-risk T-cell Lymphoblastic Lymphoma/Leukemia Post-Transplant Relapse PreventionRecruitingNCT06686108Phase 2
- A Study on the Efficacy of GD2-CAR T Cells in the Treatment of NeuroblastomaRecruitingNCT06684639Early Phase 1
- Safety and Efficacy of Systemic Allogenic NK Cells in R/R NeuroblastomaRecruitingNCT06674265Phase 1
- Low-dose Pembrolizumab Plus Chemotherapy for the First-Line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer.RecruitingNCT06670911Phase 2
- Study of ACR-2316 in Specific Advanced Solid TumorsRecruitingNCT06667141Phase 1/2
- BCL2i CLAG-M in R/R Acute Myeloid LeukemiaRecruitingNCT06660368Phase 2
- Irinotecan Liposome Combined with S-1 in PD-1/L1 Inhibitor Refractory Recurrent or Metastatic NPCRecruitingNCT06657690Phase 2
- Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Biliary Tract Cancer Recurrence SurveillanceRecruitingNCT06653127
- Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Hepatocellular Carcinoma Recurrence SurveillanceRecruitingNCT06653062
- Large Fraction Radiation Therapy Combined With Lenalidomide, and Glofitamab in Refractory Relapsed DLBCLRecruitingNCT06651853Phase 2
- fMRI and Opioid AbstinenceRecruitingNCT06651333
- Study Investigating the Safety of CD19 CAR-T Cells in Relapsed/Refractory AML Expressing CD19RecruitingNCT06649227Phase 1
- CAR-T Technology for Recurrent/Refractory Malignant Hematological and Lymphatic TumorsNot yet recruitingNCT06647329Phase 1
- Spatially Fractionated Radiation Treatment for Gynaecological CancersRecruitingNCT06644846Not applicable
- Roginolisib (IOA-244) With Venetoclax and Rituximab for Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL)RecruitingNCT06644183Phase 1/2
- A Phase I Single-arm Clinical Study of Donor NK Cells Infusion Combined With Low-dose Interleukin-2 in the Treatment of Acute Myeloid Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation.RecruitingNCT06641648Phase 1
- Study of TPEx Followed by a Maintenance With Avelumab and Cetuximab in First Line Recurrent or Metastatic Squamous Cell Carcinoma of the H&NRecruitingNCT06640725Phase 2
- Safety and Efficacy of CAR T Cell Therapy in Patients with R/r B-ALLRecruitingNCT06635330Phase 1/2
- A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell MalignanciesRecruitingNCT06634589Phase 1/2
- A National Study Examining the Most Effective Drainage Method After Burr Hole Evacuation of Chronic Subdural HematomaRecruitingNCT06621407Not applicable
- Motivational Interviews Post Hospitalisation on Maintaining AbstiNence for 1 Year après le Sevrage en AlcoolRecruitingNCT06618755Not applicable
- A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)RecruitingNCT06615479Phase 3
- A Trial to Evaluate CSF ctDNA and Safety of Plixorafenib Alone or With Retifanlimab in Patients With BRAF-altered GliomaRecruitingNCT06610682Early Phase 1
- Donafenib as Adjuvant Therapy Following Ablation for Recurrent HCCRecruitingNCT06609876Not applicable
- Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).RecruitingNCT06607692Phase 1/2
- UBX-303061 in Subjects With Relapsed/Refractory B-Cell MalignanciesRecruitingNCT06590961Phase 1
- Clinical Study on the Safety and Efficacy of CD7 CAR-T Cell in Patients With Relapsed/Refractory Acute LeukemiaRecruitingNCT06585345Phase 1/2
- Chimeric Antigen Receptor Modified T Cells Targeting BCMA for the Treatment of Relapsed/Refractory Multiple MyelomaRecruitingNCT06581640Phase 2
- Deep TMS of Neural Circuits Associated With Stimulant Use DisorderRecruitingNCT06578429Not applicable
- A Study of YKST02 in Participants With Relapsed or Refractory Multiple MyelomaRecruitingNCT06574568Phase 1
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of YK012RecruitingNCT06565689Phase 1
- Prediction of Local Recurrence and Its Impact on Long-term Outcomes After Low-risk Glans-sparing Surgery for Penile Squamous Cell CarcinomaEnrolling by invitationNCT06565585
- The Efficacy of the IUrisure for Detection of Recurrent Urothelial CarcinomaRecruitingNCT06564363
- Study Comparing Therapy for Advanced Relapsed/Refractory Multiple Myeloma With and Without DexamethasoneRecruitingNCT06561854Phase 3
- CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALLRecruitingNCT06559189Phase 1
- A Study of Selinexor in Combination With Temozolomide and Anti-PD-1 Antibody in Patients With Relapsed/Refractory Primary Central Nervous System LymphomaRecruitingNCT06556199Phase 1/2
- A Pilot Trial of Tapering Antipsychotics for Patients in Remitted Psychosis Co-administering With N-AcetylcysteineNot yet recruitingNCT06546475Phase 4
- Clinical Study on the Effect of CPAP on AF Recurrence After Catheter Ablation in Patients with AF and OSARecruitingNCT06542263
- A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.RecruitingNCT06542250Phase 1/2
- MEN1703 (SEL24) to Treat Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma (JASPIS-01)RecruitingNCT06534437Phase 2
- Phase IIa Study to Assess Safety and Efficacy in the Relapsed/Refractory Acute Myeloid LeukemiaRecruitingNCT06532058Phase 2
- LN-RADS, RECIST 1.1 and Node-RADS Classification in the Assessment of Lymph NodesRecruitingNCT06527027Not applicable
- Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHLRecruitingNCT06526793Phase 2
- A Study to Evaluate the Efficacy and Safety of the Combination of Glumetinib and Docetaxel（Albumin Bound）Verse Docetaxel for the Treatment of MET-overexpressed Non-small Cell Lung CancerNot yet recruitingNCT06525350Phase 2
- A Predictive Model for Recurrence of Colorectal Cancer Based on Multi-omics of Portal Vein BloodRecruitingNCT06524245
- A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) PhenotypeRecruitingNCT06522737Phase 3
- ELEVATE-MM: Elotuzumab, Iberdomide and Dexamethasone Post Idecabtagene Vicleucel in Relapsed and Refractory Multiple MyelomaRecruitingNCT06518551Phase 1
- Expanded Access Protocol for STOMP-II Patients Who Were Unable to Receive Treatment Subsequent to Adipose Tissue CollectionAvailableNCT06509828
- Clinical Trial Assessing the Safety and Immunologic Correlates of Heterologous Prime-Boost With pNGVL4a-Sig/E7(Detox)/HSP70 and TA-HPV in Healthy Donors Followed by Peripheral Blood CollectionEnrolling by invitationNCT06508138Phase 1
- CD19 & CD20 Bispecific CAR T Cells for Relapsed / Refractory B Cell Hematological TumorsRecruitingNCT06503094Phase 1/2
- A Study of QLS4131 in Patients With Recurrent or Refractory Multiple MyelomaNot yet recruitingNCT06500507Phase 1
- Linperlisib Combined With Immunochemotherapy in Relapsed/Refractory LBCLRecruitingNCT06489808Phase 2
- Purinostat Mesylate Combined With Pomalidomide Capsules and Low-dose Dexamethasone in Patients With Relapsed or Refractory Multiple MyelomaRecruitingNCT06484829Phase 1/2
- Effect of a Multi-strain Probiotic on Recurrent Vulvovaginal CandidiasisRecruitingNCT06480604Not applicable
- CD19-targeted CAR T Cells for Relapsed or Refractory (R/R) Large B-cell LymphomaRecruitingNCT06479356Phase 2
- Predicting Early Tumor Recurrence in Patients With Esophageal Squamous Cell CarcinomaRecruitingNCT06476067
- Dose Individualization of Chemotherapy in Patients With Gastrointestinal Cancers Lacking a Specific Liver EnzymeRecruitingNCT06475352Phase 2
- Clinical Study of Mitoxantrone Hydrochloride Liposome Combined with PD-1 Blockade in Recurrent or Metastatic NPCRecruitingNCT06472713Phase 2
- Biopsychosocial Predictors of Nicotine RelapseRecruitingNCT06470321Not applicable
- A Trial on the Remission Rates of Type I Autoimmune Pancreatits With High-risk of RecurrenceRecruitingNCT06468709Phase 4
- Master Framework For Relapse or Refractory Acute Myeloid LeukemiaRecruitingNCT06459024
- ''Comparative Evaluation of Change in Bite Force and Levels of Bone Turnover Markers CTX and BALP in Hyperdivergent and Hypodivergent Cases During Retention Phases-A Prospective Clinical Trial ''RecruitingNCT06456827Not applicable
- FOAM: Functional Outcome After Ventral Mesh RectopexyNot yet recruitingNCT06455501
- Compare the Accuracy of ctDNA-MRD and MVI Result in Predicting Postoperative Recurrence of Hepatocellular CarcinomaNot yet recruitingNCT06449846
- Interleukin-6 Receptor Inhibition for Symptomatic Intracranial AtherosclerosisNot yet recruitingNCT06447701Phase 3
- Circulating Tumor DNA Based Adjuvant Chemotherapy in Stage II Colon Cancer Patients: the MEDOCC-CrEATE TrialRecruitingNCT06434896Not applicable
- Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use DisordersRecruitingNCT06434818Phase 2
- Study of Metabolic, Transcriptomic and Proteomic Characteristics in Relapsed GlioblastomaRecruitingNCT06430424
- A Prospective Study on the Treatment of Recurrent/Refractory/Intolerable NSAA With LusutrombopagNot yet recruitingNCT06426043Phase 4
- Outpatient and Intermittent Dosing of Elranatamab in Relapsed/Refractory Multiple MyelomaRecruitingNCT06421675Phase 2
- Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning ModelRecruitingNCT06420440Phase 2
- Sequential CAR-T Cells Targeting CD33/CD123 in Patients With Acute Myelocytic Leukemia AMLRecruitingNCT06420063Phase 1/2
- Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid DepressionRecruitingNCT06419439Phase 2
- Comparison of Mesh Fixation and Non-Fixation in eTEPRecruitingNCT06417359Not applicable
- Comparison of Laparoscopic and Open Inguinal Hernia Repair in Elderly PatientsRecruitingNCT06417346Not applicable
- Developing Functional Connectivity-Guided TMS for Alcohol Use DisorderRecruitingNCT06415721Not applicable
- MRD-Directed Consolidation With Epcor-only or Epcor-R2 Post Anti-CD19 CAR TCell Therapy for Large B-Cell LymphomaRecruitingNCT06414148Phase 2
- Camrelizumab Plus Fluzoparib for TP-53 Mutated Endometrial CancerRecruitingNCT06413992Phase 2
- IM83 Clinical Study of CAR-T Cell Therapy in Patients With Relapsed or Refractory OsteosarcomaNot yet recruitingNCT06412458Phase 1
- PrEveNtion of Biliary Events After Acute Pancreatitis in NonSUrgicaL PAtients: PENINSULA TrialEnrolling by invitationNCT06409741Not applicable
- The Effectiveness and Safety of Body Posture in Preventing Postoperative Recurrence for Chronic Subdural HematomaRecruitingNCT06401772Not applicable
- Deep Phenotyping for Clinical Inferring Response in Treatment Resistant DepressionRecruitingNCT06396312